Jenny van Asbeck-van der Wijst

CEO at Mercuna BV

Speaker

Dr. Jenny van Asbeck-van der Wijst is CEO of Mercurna B.V., a Dutch biotech developing targeted mRNA-based therapeutics for inflammatory and immune-driven diseases. Combining a background in biomedical research with executive business training, she has led multiple European innovation programs translating scientific discoveries into therapeutic and commercial opportunities. She currently leads Mercurna's efforts to advance targeted delivery platforms designed for difficult-to-reach tissues, including kidney and bone marrow, with applications in rare diseases and other areas of high unmet medical needs.